English Guthrie
Family · Columbus, GANPI 1831847144
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 25.4% of the total. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $25.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$1K
- GSK$1K
- Sanofi$1K
- AbbVie$468
- Genentech USA, Inc.$288
- plus $2K from 21 others
What the payments were for
- Food & beverage$7,60298%
- Education$1822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 76 | $1,974 |
| Regeneron Healthcare Solutions, Inc. | 39 | $1,160 |
| GSK | 55 | $1,096 |
| Sanofi | 33 | $1,009 |
| AbbVie | 16 | $468 |
| Genentech USA, Inc. | 9 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $240 |
| Novartis | 13 | $236 |
| CSL Behring | 8 | $194 |
| Biocryst US Sales Co., LLC | 9 | $188 |
| Amgen | 8 | $188 |
| Galderma Laboratories, L.p. | 2 | $154 |
| Lilly USA, LLC | 4 | $106 |
| Grifols USA, LLC | 4 | $80 |
| Kaleo, Inc. | 3 | $65 |
| Sanofi-aventis U.S. LLC | 1 | $56 |
| Pfizer | 2 | $49 |
| Alk-abello, Inc | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Verona Pharma, Inc. | 1 | $29 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Pharming Healthcare, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Dermavant Sciences, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Octapharma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,784 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 19 | $795 |
| Fluticasone Propionate | 39 | $624 |
| Azelastine Hcl | 19 | $481 |
| Levocetirizine Dihydrochloride | 23 | $472 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $471 |
| Montelukast Sodium | 34 | $278 |
| Prednisone | 18 | $21 |
Paid to pharmacies, not to this prescriber.
Other family in Columbus
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.